Lee Ainslie Alnylam Pharmaceuticals, Inc. Transaction History

Maverick Capital LTD

$4.82 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $635,527 - $833,602	-3,983 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $49 Million - $60 Million	-288,700 Reduced 98.64%	3,983 $752,000
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $64.8 Million - $89.1 Million	-503,551 Reduced 63.24%	292,683 $49.6 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $23.9 Million - $33.1 Million	-188,268 Reduced 19.12%	796,234 $112 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $2.1 Million - $2.51 Million	17,041 Added 1.76%	984,502 $128 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $17.7 Million - $24.2 Million	-146,147 Reduced 13.12%	967,461 $141 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $23.6 Million - $35.4 Million	-226,097 Reduced 16.88%	1,113,608 $165 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $85.8 Million - $123 Million	-921,192 Reduced 40.74%	1,339,705 $146 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $71.7 Million - $119 Million	-961,916 Reduced 29.85%	2,260,897 $260 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $71.8 Million - $89 Million	-1,013,203 Reduced 23.92%	3,222,813 $259 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $67.5 Million - $95.2 Million	1,025,629 Added 31.95%	4,236,016 $307 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $29.6 Million - $38 Million	406,436 Added 14.5%	3,210,387 $300 Million
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $81 Million - $114 Million	1,291,887 Added 85.44%	2,803,951 $204 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $72.7 Million - $102 Million	830,710 Added 121.92%	1,512,064 $132 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $60.2 Million - $73.4 Million	681,354 New	681,354 $67.1 Million

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.04 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.09 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.34 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.28 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.21 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track Lee Ainslie's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Account